XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income (loss) $ 6,080 $ (421)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:    
Depreciation and amortization 3,379 3,391
Share based compensation (7,631) 3,489
Deferred income taxes (696) (146)
Bad debt expense 176 36
(Increase) decrease in operating assets and increase (decrease) in operating liabilities:    
Accounts receivable 1,488 (345)
Inventories, net 15,464 3,237
Prepaid income taxes (179) 426
Prepaid expenses and other current assets 2,670 (3,516)
Operating lease right-of-use assets, net 245 394
Accounts payable (20,071) (5,542)
Sales tax payable (639) (1,278)
Accrued expenses and other current liabilities (221) (136)
Lease liabilities (240) (383)
Deferred revenue (953) 579
Net cash (used in) provided by operating activities (1,128) (215)
Cash flows from investing activities:    
Acquisition of PetCareRx, net of cash acquired 0 (35,859)
Purchases of property and equipment (1,948) (2,137)
Net cash used in investing activities (1,948) (37,996)
Cash flows from financing activities:    
Dividends paid (175) (12,404)
Net cash used in financing activities (175) (12,404)
Net decrease in cash and cash equivalents (3,251) (50,615)
Cash and cash equivalents, at beginning of period 55,296 104,086
Cash and cash equivalents, at end of period 52,045 53,471
Supplemental disclosure of cash flow information:    
Cash paid for income taxes 466 0
Dividends payable in accrued expenses and other current liabilities $ 39 $ 1,513